{
    "Trade/Device Name(s)": [
        "artus\u00ae C. difficile QS-RGQ MDx Kit"
    ],
    "Submitter Information": "QIAGEN GmbH",
    "510(k) Number": "K133936",
    "Predicate Device Reference 510(k) Number(s)": [
        "K123998"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZN"
    ],
    "Summary Letter Date": "January 6, 2014",
    "Summary Letter Received Date": "January 6, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.3130"
    ],
    "Regulation Name(s)": [
        "Clostridium difficile toxin gene amplification assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Clostridium difficile toxin A gene (tcdA)",
        "Clostridium difficile toxin B gene (tcdB)",
        "Clostridium difficile toxin B variant gene (tcdBv)"
    ],
    "Specimen Type(s)": [
        "Liquid stool",
        "Soft stool"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "QIAsymphony SP",
        "QIAsymphony AS",
        "Rotor-Gene Q MDx",
        "QIAsymphony RGQ MDx system"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "DNA amplification",
        "Fluorescently labeled oligonucleotide probes"
    ],
    "Methodologies": [
        "Polymerase chain reaction (PCR)",
        "Molecular detection"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Reagent",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for artus C. difficile QS-RGQ MDx Kit, a PCR assay for qualitative detection of C. difficile toxin A and B genes in human stool specimens",
    "Indications for Use Summary": "Qualitative detection of toxigenic Clostridium difficile toxin A and toxin B genes in human liquid or soft stool specimens from patients suspected of having C. difficile associated disease, to aid in the diagnosis of C. difficile infection.",
    "fda_folder": "Microbiology"
}